Ani Pharmaceuticals (ANIP) EPS (Diluted) Growth (5y) (2016 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EPS (Diluted) Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.29% |
| Mar 31, 2026 | 189.43% |
| Dec 31, 2025 | 44.43% |
| Sep 30, 2025 | 100.36% |
| Jun 30, 2025 | 19.02% |
| Mar 31, 2025 | 26.94% |
| Dec 31, 2024 | -6.61% |
| Sep 30, 2024 | -42.56% |
| Jun 30, 2024 | -17.71% |
| Mar 31, 2024 | 89.03% |
| Dec 31, 2023 | -38.32% |
| Sep 30, 2023 | 3.16% |
| Jun 30, 2023 | 6.78% |
| Mar 31, 2023 | -20.13% |
| Dec 31, 2022 | -16.87% |
| Sep 30, 2022 | -22.90% |
| Jun 30, 2022 | -32.64% |
| Mar 31, 2022 | -54.30% |
| Dec 31, 2021 | -60.05% |
| Sep 30, 2021 | -20.74% |